How common are pharmacokinetic and pharmacodynamic abnormalities in patients with severe asthma?

被引：0
|
作者：
Spahn, J. [1 ]
Doshi, J. [1 ]
Brown, E. [1 ]
Covar, R. [1 ]
机构：
[1] Univ Colorado, Natl Jewish Med & Res Ctr, Denver, CO USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 121卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2007.12.1031
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1005
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019
    McEneny-King, Alanna C.
    Monteleone, Jonathan P. R.
    Kazani, Shamsah D.
    Ortiz, Stephan R.
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (02) : 1045 - 1054
  • [32] DICHLOROACETATE FOR LACTIC-ACIDOSIS IN SEVERE MALARIA - A PHARMACOKINETIC AND PHARMACODYNAMIC ASSESSMENT
    KRISHNA, S
    SUPANARANOND, W
    PUKRITTAYAKAMEE, S
    KARTER, D
    SUPPUTAMONGKOL, Y
    DAVIS, TME
    HOLLOWAY, PA
    WHITE, NJ
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (08): : 974 - 981
  • [33] Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019
    Alanna C. McEneny-King
    Jonathan P. R. Monteleone
    Shamsah D. Kazani
    Stephan R. Ortiz
    Infectious Diseases and Therapy, 2021, 10 : 1045 - 1054
  • [34] Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis
    Greenzaid, Jonathan
    Feldman, Steven
    CLINICAL PHARMACOKINETICS, 2024, 63 (02) : 137 - 153
  • [35] Assessing the viability of long-acting β2-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective
    Matera, Maria Gabriella
    Rinaldi, Barbara
    Calzetta, Luigino
    Cazzola, Mario
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (02) : 129 - 136
  • [36] Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Crass, Ryan L.
    Smith, Brandon
    Adriaens, Sven
    Chapel, Sunny
    Langdon, Grant
    DRUGS IN R&D, 2024, 24 (04) : 563 - 573
  • [37] Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
    Carrothers, Timothy J.
    Lagraauw, H. Maxime
    Lindbom, Lars
    Riccobene, Todd A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (02) : 99 - 105
  • [38] Pharmacokinetic and pharmacodynamic surrogate markers: Studies with fluoroquinolones in patients
    Schentag, JJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 : S21 - S24
  • [39] PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF PROPAFENONE IN PATIENTS WITH VENTRICULAR ARRHYTHMIA
    ZOBLE, RG
    KIRSTEN, EB
    BREWINGTON, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) : 535 - 541
  • [40] Pharmacokinetic/pharmacodynamic effects of dexmedetomidine in patients with hepatic failure
    Baughman, VL
    Cunningham, FE
    Layden, T
    Tonkovich, L
    ANESTHESIA AND ANALGESIA, 2000, 90 (02): : U231 - U231
12345